Bio LaunchPad Seminar

BioTools Innovator is unique among accelerators with its focus on life science research tools. Join the seminar to learn about the BioTools Innovator program directly from a program participant and now Associate Director of the Accelerator and hear from a company (Andson Biotech) that graduated from the program. There will be ample time for Q&A.

REGISTER HERE to participate via Zoom

REGISTER HERE to attend in-person. 
*Lunch provided for in-person attendees, while supplies last

Speakers:
Mason Chilmonczyk
Chief Executive Officer, Co-founder
Andson Biotech

Jim West III, MS
Associate Director
BioTools Innovator

Mason Chilmonczyk BIO
Mason developed the DynaCHIP technology for his Ph.D. dissertation at the Georgia Institute of Technology under Andrei G. Fedorov, Ph.D. During his postdoc, Mason served as the entrepreneurial and technical lead for the project, securing Biolocity and Georgia Research Alliance funding to support the development of the technology.

‍Mason formally cofounded Andson Biotech with Andrei just before it was backed by the well-known accelerator, Ycombinator, for their Winter 2022 batch. Under Mason's leadership, Andson was selected into Merck Pharmaceutical's inaugural accelerator program, the Merck Digital Sciences Studio (2022-2023), as well as the prestigious BioTools Innovator program (2023), where Andson was selected as a top 4 finalist.

Mason has served as a consultant on projects ranging from artificial intelligence cancer diagnosis to resonance-based diagnostics sensors. Before starting his PhD, Mason worked in hands on roles that have benefitted him tremendously as an engineer including a position at a sheet metal/frame shop and as a design engineer for a pharmaceutical packaging company.

Jim West BIO
Jim West has spent his career at the intersection of health, business, and technology serving as an engineer, advisor, consultant and CEO to early stage and growing companies. Currently he serves as the Associate Director at BioTools Innovator, the worlds premier accelerator for life science companies. As former co-founder and CEO of Clara Biotech, Jim has been pivotal in pioneering patented breakthroughs in exosome purification and sample preparation, helping address some of the most challenging issues in the field. Prior to Clara Biotech, Jim work on developing medical products from prototyping through manufacturing. Jim's expertise and leadership were instrumental in securing FDA approval for one of the first mobile medical devices in 2016 using an iPhone as a stethoscope. Jim has dual master's degrees in Biomedical Engineering (from the University of Kansas) and Entrepreneurship (Nanyang Technological University, Singapore).